Huge recurrent gastric neuroendocrine tumor: a second-line chemotherapeutic dilemma


Chemotherapy is considered "state of the art" for the treatment of poorly differentiated neuroendocrine neoplasms. Unfortunately, there is no standard effective post-first-line treatment for relapsing high-grade gastroenteropancreatic neuroendocrine neoplasms. We report the case of a patient with a gastric neuroendocrine carcinoma stage IV, with massive… (More)
DOI: 10.4322/acr.2018.005

4 Figures and Tables


  • Presentations referencing similar topics